Moody Aldrich Partners LLC Igm Biosciences, Inc. Transaction History

Moody Aldrich Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$27.59 - $66.39 $633,245 - $1.52 Million	-22,952 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$65.76 - $90.65 $793,065 - $1.09 Million	-12,060 Reduced 34.45%	22,952 $1.51 Million
Q2 2021 Aug 04, 2021	SELL	$57.98 - $96.6 $24,467 - $40,765	-422 Reduced 1.19%	35,012 $2.91 Million
Q1 2021 May 10, 2021	BUY	$71.56 - $121.23 $968,493 - $1.64 Million	13,534 Added 61.8%	35,434 $2.72 Million
Q4 2020 Feb 16, 2021	SELL	$47.41 - $115.03 $750,832 - $1.82 Million	-15,837 Reduced 41.97%	21,900 $1.93 Million
Q3 2020 Nov 12, 2020	BUY	$43.0 - $84.01 $811,152 - $1.58 Million	18,864 Added 99.95%	37,737 $2.79 Million
Q2 2020 Jul 30, 2020	BUY	$51.3 - $75.21 $968,184 - $1.42 Million	18,873 New	18,873 $1.38 Million

15.4M

26.8K

800

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $36.8M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Aldrich Partners LLC with notifications on news.